rs138838276
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 2P and 9B. PM2BP4_StrongBP6BS1
The NM_178452.6(DNAAF1):āc.1499C>Gā(p.Pro500Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000143 in 1,611,858 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_178452.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
DNAAF1 | NM_178452.6 | c.1499C>G | p.Pro500Arg | missense_variant | 8/12 | ENST00000378553.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
DNAAF1 | ENST00000378553.10 | c.1499C>G | p.Pro500Arg | missense_variant | 8/12 | 1 | NM_178452.6 | P1 | |
DNAAF1 | ENST00000563818.5 | n.1176C>G | non_coding_transcript_exon_variant | 4/8 | 2 | ||||
DNAAF1 | ENST00000570298.5 | n.1653C>G | non_coding_transcript_exon_variant | 8/11 | 2 | ||||
DNAAF1 | ENST00000563093.5 | c.*54C>G | 3_prime_UTR_variant, NMD_transcript_variant | 9/11 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000637 AC: 97AN: 152180Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000181 AC: 45AN: 248722Hom.: 0 AF XY: 0.0000962 AC XY: 13AN XY: 135088
GnomAD4 exome AF: 0.0000911 AC: 133AN: 1459560Hom.: 1 Cov.: 94 AF XY: 0.0000702 AC XY: 51AN XY: 726174
GnomAD4 genome AF: 0.000637 AC: 97AN: 152298Hom.: 0 Cov.: 32 AF XY: 0.000618 AC XY: 46AN XY: 74466
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 21, 2023 | - - |
Likely benign, criteria provided, single submitter | clinical testing | UNC Molecular Genetics Laboratory, University of North Carolina at Chapel Hill | Jan 11, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2019 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Feb 15, 2016 | Variant classified as Uncertain Significance - Favor Benign. The p.Pro500Arg var iant in DNAAF1 has not been previously reported in individuals with pulmonary di sease, but has been identified in 0.25% (24/9432) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs1388 38276). Computational prediction tools and conservation analysis suggest that th e p.Pro500Arg variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clinical si gnificance of the p.Pro500Arg variant is uncertain, its frequency suggests that it is more likely to be benign. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 27, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at